Certolizumab and anti-Certolizumab antibody-994

Test info

  
Certolizumab and anti-Certolizumab antibody
  
994
  
LAB994
  
MSO
  
Anti-TNF
Anti-TNF drug
Biologic drug level and anti-drug antibody
Biologic monitoring

Cimzia
DoseASSURE
Immunogenicity testing
TDM
TNF inhibitor
  
Certolizumab drug level, anti-certolizumab antibodies and serial monitoring
  

Provides certolizumab drug concentration and anti-certolizumab antibodies in order to optimize treatment and facilitate clinical decision-making. This assay may be helpful in any patient on certolizumab therapy for Crohn's disease, psoriasis, or other autoimmune condition.

Specimen

  
Serum
  
  
2.0 mL
  
0.6 mL
  

Immediately following collection, mix sample by gently inverting 5 times

  
  1. Allow sample to clot for a minimum of 30 minutes
  2. Spin within two (2) hours of sample collection
  3. Transfer serum to a Transfer vial/tube with cap - 12mL (LabCorp), labelled as serum
  

Gold serum separator (SST) tube

 

  
  
  1. Allow sample to clot 
  2. Spin within two (2) hours of sample collection 
  3. Transfer serum to a Transfer vial/tube with cap - 12mL (LabCorp), labelled as serum
  
  

Refrigerated (preferred) - 14 days

Frozen - 14 days

Freeze/thaw cycles: stable x 6

Ambient - 18 hours

  
  • Gross hemolysis
  • Gross lipemia

Performance

  
Esoterix Endocrinology (804627) via LabCorp (504627) : R-NX
  
Mo
  
8 - 15 days
  

Electrochemiluminescence Immunoassay (ECLIA); Surface Plasmon Resonance

Clinical and Interpretive info

  

An interpretive report will be provided

Billing

  
80299
82397

Tracking

  
08/29/2019
  
12/20/2023
  
12/20/2023